Replies to post #1720 on Revance Therapeutics Inc (RVNC)

[floblu14]

AbbVie unit wins ITC trade secret case against Evolus, Bloomberg

AbbVie's (ABBV) Allergan unit won an order to block Evolus (EOLS) and partner Daewoong from importing Jeuveau into the U.S. for 21 months, reported Bloomberg's Susan Decker and Christopher Yasiejko. Jeuveau is a rival to Allergan's wrinkle treatment Botox. Following the report, Evolus shares are down 46c, or 11%, to $3.57 in afternoon trading.